Fatal Myocarditis -- Rare New ADR With Immunotherapy Fatal Myocarditis -- Rare New ADR With Immunotherapy
Fatal myocarditis has been reported in melanoma patients treated with ipilimumab and nivolumab; this appears to be a rare T-cell-driven reaction.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Health | Hematology | Immunotherapy | Melanoma | Myocarditis | Skin Cancer | Yervoy